Can Remote CRP Testing Transform Rheumatology Care? Insights from Hemetron
In this special episode, recorded live in Berlin at the 7th Digital Rheumatology Days meeting, we’re joined by Yves Blickenstorfer, CTO of Hemetron and graduate of ETH Zürich. Hemetron, an emerging ETH spinoff, is pioneering a novel approach to regular remote CRP testing — a crucial biomarker for monitoring inflammatory diseases.
In our conversation, we explore how Hemetron’s technology could transform clinical care in rheumatology. We delve into the real-world potential of remote testing, the ways it can empower patients with chronic conditions, and the hurdles to widespread adoption — from usability and accuracy to patient trust and integration into care systems.
Whether you’re a clinician, researcher, or digital health innovator, this episode offers valuable perspectives on the evolving landscape of biomarker-driven remote care.
Can Remote CRP Testing Transform Rheumatology Care? Insights from Hemetron
If you like to get more intersting content please become a member or if you are already a member go to the member area directly: